DexCom
$86.23Change from previous close: −0.07%Absolute change: −$0.06
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $32.54B
- Enterprise value
- $31.99B
- P/E (trailing 12 months)
- 34.1
- Forward P/E
- 27.6
- PEG
- 1.33
- Price/book
- 12.4
- Price/sales
- 6.55
- EV/EBITDA
- 22.8
- EV/revenue
- 6.44
Profitability and growth
- Gross margin
- 62.5%
- Operating margin
- 24.3%
- Net margin
- 20.1%
- ROE
- 38.5%
- ROA
- 10.3%
- Revenue growth (year over year)
- 13.1%
- Earnings growth (year over year)
- 43.6%
Financial health
- Total cash
- $1.95B
- Total debt
- $1.4B
- Debt/equity
- 0.53
- Current ratio
- 1.73
- Quick ratio
- 1.37
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $95.08
- Median price target
- $95.00
- High price target
- $115.00
- Low price target
- $79.00
- Analysts with a price target
- 25
- Consensus
- Strong buy
- Forward EPS
- $3.12
- EPS estimate, current year
- $2.66
Shares and trading
- Beta
- 1.42
- Average volume
- 4.6M
- Shares outstanding
- 377.36M
- Float
- 375.99M
- Institutional ownership
- 106.6%
- Insider ownership
- 0.3%
- Short interest (% of float)
- 5.3%
- Short ratio (days)
- 4.49